These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34445019)

  • 1. Understanding the Protective Effect of Phytate in Bone Decalcification Related-Diseases.
    Sanchis P; López-González ÁA; Costa-Bauzá A; Busquets-Cortés C; Riutord P; Calvo P; Grases F
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated Phytate Intake Is Associated with Bone Mineral Density in Mediterranean Postmenopausal Women.
    Sanchis P; Prieto RM; Konieczna J; Grases F; Abete I; Salas-Salvadó J; Martín V; Ruiz-Canela M; Babio N; García-Gavilán JF; Goday A; Costa-Bauza A; Martínez JA; Romaguera D
    Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of consumption of phytate on the bone mass in posmenopausal women of Mallorca].
    López-González AA; Grases F; Marí B; Vicente-Herrero MT; Costa-Bauzá A; Monroy N
    Reumatol Clin; 2011; 7(4):220-3. PubMed ID: 21794821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytate (myo-inositol hexaphosphate) and risk factors for osteoporosis.
    López-González AA; Grases F; Roca P; Mari B; Vicente-Herrero MT; Costa-Bauzá A
    J Med Food; 2008 Dec; 11(4):747-52. PubMed ID: 19053869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis.
    Iwamoto J; Takeda T; Sato Y; Uzawa M
    Yonsei Med J; 2005 Dec; 46(6):750-8. PubMed ID: 16385649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate.
    Watts NB; Becker P
    Bone; 1999 Jan; 24(1):65-8. PubMed ID: 9916786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Effect of Myo-Inositol Hexaphosphate (Phytate) on Abdominal Aortic Calcification in Patients With Chronic Kidney Disease.
    Sanchis P; Buades JM; Berga F; Gelabert MM; Molina M; Íñigo MV; García S; Gonzalez J; Bernabeu MR; Costa-Bauzá A; Grases F
    J Ren Nutr; 2016 Jul; 26(4):226-36. PubMed ID: 26975775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?
    Sawka AM; Ioannidis G; Papaioannou A; Thabane L; Olszynski WP; Brown JP; Hanley DA; Murray TM; Josse RG; Sebaldt RJ; Petrie A; Tenenhouse A; Goldsmith CH; Boulos P; Kouroukis T; Adachi JD
    J Obstet Gynaecol Can; 2005 Aug; 27(8):759-64. PubMed ID: 16287007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to alendronate in osteoporosis after previous treatment with etidronate.
    Fairney A; Kyd P; Thomas E; Wilson J
    Osteoporos Int; 2000; 11(7):621-5. PubMed ID: 11069197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary phytate concentration and risk of fracture determined by the FRAX index in a group of postmenopausal women.
    Gonzalez AAL; Grases F; Mari B; Tomas-Salva M; Rodriguez A
    Turk J Med Sci; 2019 Apr; 49(2):458-463. PubMed ID: 30862150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3.
    Gilfraguas L; Guadalix S; Martinez G; Jodar E; Vara J; Gomez-Sanchez MA; Delgado J; De La Cruz J; Lora D; Hawkins F
    Prog Transplant; 2012 Sep; 22(3):237-43. PubMed ID: 22951500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis. effect of adding hormone replacement therapy.
    Cortet B; Béra-Louville A; Gauthier P; Gauthier A; Marchandise X; Delcambre B
    Joint Bone Spine; 2001 Oct; 68(5):410-5. PubMed ID: 11707007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.
    Reid DM; Hosking D; Kendler D; Brandi ML; Wark JD; Marques-Neto JF; Weryha G; Verbruggen N; Hustad CM; Mahlis EM; Melton ME
    Int J Clin Pract; 2008 Apr; 62(4):575-84. PubMed ID: 18324951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early response to alendronate after treatment with etidronate in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S; Uzawa M
    Keio J Med; 2003 Jun; 52(2):113-9. PubMed ID: 12862363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis.
    Atmaca A; Gedik O
    Adv Ther; 2006; 23(6):842-53. PubMed ID: 17276952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study.
    Olszynski WP; Davison KS; Ioannidis G; Brown JP; Hanley DA; Josse RG; Murray TM; Papaioannou A; Sebaldt RJ; Tenenhouse AM; Petrie A; Goldsmith CH; Adachi JD
    Osteoporos Int; 2006 Feb; 17(2):217-24. PubMed ID: 15997420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications.
    Grases F; Costa-Bauza A
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31817119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts.
    Shu G; Yamamoto K; Nagashima M
    Mod Rheumatol; 2006; 16(6):343-9. PubMed ID: 17164994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion.
    Prieto RM; Fiol M; Perello J; Estruch R; Ros E; Sanchis P; Grases F
    Eur J Nutr; 2010 Sep; 49(6):321-6. PubMed ID: 20108098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.